Ptc Therapeutics reported $23.61M in Interest Expense on Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Alnylam Pharmaceuticals ALNY:US $ 42.36M 5.55M
Amgen AMGN:US $ 295M 40M
Biocryst Pharmaceuticals BCRX:US $ 23.84M 5.06M
Biogen BIIB:US $ 66.1M 0.2M
Biomarin Pharmaceutical BMRN:US $ 3.81M 0.04M
Cytokinetics CYTK:US $ 2.75M 1.47M
Esperion Therapeutics ESPR:US $ 14.06M 632K
Gilead Sciences GILD:US $ 238M 0M
Intercept Pharmaceuticals ICPT:US $ 6.67M 8.64M
IONIS PHARMACEUT IONS:US $ 2.12M 0.12M
Ironwood Pharmaceuticals IRWD:US $ 2.34M 5.61M
Karyopharm Therapeutics KPTI:US $ 6.68M 1.26M
Novartis NOVN:VX 201M 5M
Pfizer PFE:US $ 322M 6M
Ptc Therapeutics PTCT:US $ 23.61M 1.01M
Puma Biotechnology PBYI:US $ 2.66M 0.05M
Sarepta Therapeutics SRPT:US $ 15.8M 0.25M
Tg Therapeutics TGTX:US $ 2.66M 1.58M
Vertex Pharmaceuticals VRTX:US $ 14.9M 0.19M
YTE INCY:US $ 0.68M 0.07M